UA41245C2 - Похідні піримідину, спосіб їх одержання та фармацевтична композиція на їх основі - Google Patents

Похідні піримідину, спосіб їх одержання та фармацевтична композиція на їх основі

Info

Publication number
UA41245C2
UA41245C2 UA4742852A UA4742852A UA41245C2 UA 41245 C2 UA41245 C2 UA 41245C2 UA 4742852 A UA4742852 A UA 4742852A UA 4742852 A UA4742852 A UA 4742852A UA 41245 C2 UA41245 C2 UA 41245C2
Authority
UA
Ukraine
Prior art keywords
preparation
pharmaceutical composition
composition based
pyrimidine derivatives
compounds
Prior art date
Application number
UA4742852A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Ейнслі Міллер Елістейр
Ейнсли Миллер Элистейр
Стюарт Ноббз Малькольм
Мартін Гайд Річард
Мартин Гайд Ричард
Джон Ліч Майкл
Джон Лич Майкл
Original Assignee
Дзе Веллкам Фаундейшн Лімітед
Дзе Веллкам Фаундейшн Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828620A external-priority patent/GB8828620D0/en
Priority claimed from GB898908561A external-priority patent/GB8908561D0/en
Priority claimed from GB8918893A external-priority patent/GB8918893D0/en
Application filed by Дзе Веллкам Фаундейшн Лімітед, Дзе Веллкам Фаундейшн Лимитед filed Critical Дзе Веллкам Фаундейшн Лімітед
Publication of UA41245C2 publication Critical patent/UA41245C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/58—Two sulfur atoms
UA4742852A 1988-12-07 1989-12-06 Похідні піримідину, спосіб їх одержання та фармацевтична композиція на їх основі UA41245C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888828620A GB8828620D0 (en) 1988-12-07 1988-12-07 Pharmaceutically active cns compounds
GB898908561A GB8908561D0 (en) 1989-04-14 1989-04-14 Pharmaceutically active cns compounds
GB8918893A GB8918893D0 (en) 1989-08-18 1989-08-18 Pharmacologically active cns compounds

Publications (1)

Publication Number Publication Date
UA41245C2 true UA41245C2 (uk) 2001-09-17

Family

ID=27264228

Family Applications (2)

Application Number Title Priority Date Filing Date
UA4742852A UA41245C2 (uk) 1988-12-07 1989-12-06 Похідні піримідину, спосіб їх одержання та фармацевтична композиція на їх основі
UA99116068A UA42885C2 (uk) 1988-12-07 1999-11-04 4-аміно-2-(4-метилпіперазин-1-іл)-5-(2,3,5-трихлорфеніл)піримідин, що має інгібуючу активність вивільнення глутамату, спосіб його одержання та фармацевтична композиція на його основі

Family Applications After (1)

Application Number Title Priority Date Filing Date
UA99116068A UA42885C2 (uk) 1988-12-07 1999-11-04 4-аміно-2-(4-метилпіперазин-1-іл)-5-(2,3,5-трихлорфеніл)піримідин, що має інгібуючу активність вивільнення глутамату, спосіб його одержання та фармацевтична композиція на його основі

Country Status (36)

Country Link
US (7) US5597827A (xx)
EP (8) EP0372934B1 (xx)
JP (1) JP2795498B2 (xx)
KR (1) KR0145308B1 (xx)
CN (5) CN1052306A (xx)
AP (1) AP164A (xx)
AT (4) ATE384703T1 (xx)
AU (5) AU669929B2 (xx)
CA (2) CA2271566C (xx)
CY (1) CY2139B1 (xx)
DD (1) DD292250A5 (xx)
DE (4) DE68929460T2 (xx)
DK (2) DK175796B1 (xx)
ES (4) ES2194884T3 (xx)
FI (4) FI895821A0 (xx)
GE (1) GEP19970891B (xx)
GR (1) GR3022031T3 (xx)
HK (1) HK1004092A1 (xx)
HU (3) HUT55764A (xx)
IE (1) IE80711B1 (xx)
IL (7) IL114335A (xx)
LT (1) LT3415B (xx)
LV (1) LV10442B (xx)
MC (1) MC2076A1 (xx)
MX (1) MX9203422A (xx)
MY (1) MY115951A (xx)
NO (4) NO178926C (xx)
NZ (4) NZ260820A (xx)
OA (1) OA09148A (xx)
PH (1) PH31658A (xx)
PL (1) PL162957B1 (xx)
PT (1) PT92502B (xx)
RU (2) RU2079493C1 (xx)
SG (1) SG43314A1 (xx)
SK (2) SK689889A3 (xx)
UA (2) UA41245C2 (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
GB9012316D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
ATE133068T1 (de) * 1991-01-30 1996-02-15 Wellcome Found Wasserlösliche tabletten
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
GB9226377D0 (en) * 1992-12-18 1993-02-10 Babbedge Rachel C Pharmaceutical compositions
WO1994014780A1 (en) * 1992-12-18 1994-07-07 The Wellcome Foundation Limited Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
AU7513794A (en) * 1993-09-10 1995-03-27 E.I. Du Pont De Nemours And Company Improved process for preparing 2-amino-4,6-dichloropyrimidine
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
IT1300056B1 (it) * 1998-04-17 2000-04-05 Boehringer Ingelheim Italia Eterocicli con anello a 6 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmaci
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
AR029489A1 (es) * 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
US7205297B2 (en) 2000-07-24 2007-04-17 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
AR037233A1 (es) * 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
PL371059A1 (en) * 2001-11-19 2005-06-13 Basf Aktiengesellschaft 5-phenylpyrimidines, agents comprising the same, method for production and use thereof
GB0300783D0 (en) * 2003-01-14 2003-02-12 Btg Int Ltd Treatment of neurodegenerative conditions
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
AU2005245580A1 (en) * 2004-05-19 2005-12-01 Basf Aktiengesellschaft 2-substituted pyrimidines and their use as pesticides
ZA200701232B (en) 2004-07-15 2008-08-27 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
EP2129381A1 (en) * 2007-01-24 2009-12-09 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
GB0800741D0 (en) 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
JP5369093B2 (ja) * 2008-03-31 2013-12-18 全薬工業株式会社 細胞保護作用を有するピリミジン誘導体およびその用途
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
CN101343253B (zh) * 2008-06-24 2011-03-16 陕西师范大学 2-氨基-4,5-二芳基嘧啶类化合物及其制备方法和药物用途
WO2010132437A1 (en) 2009-05-12 2010-11-18 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
JP5739415B2 (ja) 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
WO2013138787A1 (en) * 2012-03-16 2013-09-19 The Board Of Regents For Oklahoma State University Highly 6-substituted -2,4-diaminopyrimidines as inhibitors of anthrax
DE102013100799A1 (de) * 2012-12-21 2014-06-26 Endress + Hauser Flowtec Ag Umformerschaltung mit einer Stromschnittstelle sowie Meßgerät mit einer solchen Umformerschaltung
TWI644899B (zh) * 2013-02-04 2018-12-21 健生藥品公司 Ｆｌａｐ調節劑
US9745328B2 (en) 2013-02-04 2017-08-29 Janssen Pharmaceutica Nv Flap modulators
GB2560903A (en) 2017-03-27 2018-10-03 Azad Pharmaceutical Ingredients Ag New synthetic path to pharmaceutically acceptable vismodegib
GB202006080D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Cytokine storm syndrome
GB202006076D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Interleukin inhibitors

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2602794A (en) * 1952-07-08 Process for preparation of x-amino-s
CA741825A (en) * 1966-08-30 Stenbuck Paul Propionitrile condensation intermediates
US2594309A (en) * 1952-04-29 Antimalarial agents and method of
US2624731A (en) * 1953-01-06 S-phenylpyrimidkn e x derivativesx
BE518622A (xx) *
US2576939A (en) * 1951-12-04 -diamino-s-phenyl-e-alkyl-
CH207759A (de) * 1938-03-07 1939-11-30 Mayer & Schmidt Schleifmaschin Feinbohrspindel mit radial verschiebbarem Werkzeugträger.
GB691020A (en) * 1950-02-15 1953-05-06 Wellcome Found Improvements in or relating to pyrimidine derivatives of therapeutic value and to the manufacture thereof
GB715813A (en) * 1950-06-14 1954-09-22 Wellcome Found Improvements in derivatives of pyrimidine
US2688019A (en) * 1951-08-25 1954-08-31 Burroughs Wellcome Co 6-aryl-2,4-diamino pyrimidines and process of preparing same
DE956306C (de) * 1952-01-30 1957-01-17 Rhone Poulenc Sa Verfahren zur Herstellung von neuen Derivaten des Pyrimidins
DE951991C (de) * 1952-01-30 1956-11-08 Rhone Poulenc Sa Verfahren zur Herstellung von neuen chlorierten Derivaten des Pyrimidins
GB760944A (en) * 1952-11-04 1956-11-07 Wellcome Found Improvements in and relating to pyrimidine derivatives and their manufacture
DE1009188B (de) * 1953-05-21 1957-05-29 Rhone Poulenc Sa Verfahren zur Herstellung von Pyrimidinderivaten
DE1303727B (de) * 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
DE1670854B2 (de) * 1967-04-20 1977-04-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4,6- trichlorpyrimidinen
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
US4005204A (en) * 1973-03-23 1977-01-25 Burroughs Wellcome Co. Treatment of neoplasms in the brain with diamino dichloroalkyl pyrimidine
US4006235A (en) * 1973-03-23 1977-02-01 Burroughs Wellcome Co. Treating CNS lymphoma
US4005203A (en) * 1973-03-23 1977-01-25 Burroughs Wellcome Co. Treatment of meningeal leukemia with diamino dichlorophenyl pyrimidine
CH591457A5 (xx) * 1973-11-08 1977-09-15 Hoffmann La Roche
US3940393A (en) * 1974-06-21 1976-02-24 American Home Products Corporation Synthesis of 2,6-diaminopyrimidines
FR2306697A1 (fr) * 1975-04-10 1976-11-05 Sogeras Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
ZA818204B (en) * 1980-11-27 1983-07-27 Wellcome Found Antibacterial benzylpyrimidines
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
FR2535718A1 (fr) * 1982-11-09 1984-05-11 Sanofi Sa (piperazinyl-1)-2 pyrimidines, leurs sels, procede pour leur preparation et compositions pharmaceutiques en contenant
US4496549A (en) * 1983-01-17 1985-01-29 American Cyanamid Company Treatment of malaria with antibiotics
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3411571A1 (de) * 1984-03-29 1985-10-10 Merck Patent Gmbh, 6100 Darmstadt Pyrimidine
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
DE3752141T2 (de) * 1986-02-24 1998-03-26 Mitsui Petrochemical Ind Mittel zur behandlung von neuropathie
AR242678A1 (es) * 1986-03-05 1993-04-30 Gonzalez Jorge Alberto Mejoras en instrumentos musicales de cuerda de arco.
DE3620841A1 (de) * 1986-06-21 1987-12-23 Basf Ag 4-aminopyrimidinderivate
FR2602507B1 (fr) * 1986-08-08 1989-06-09 Sanofi Pharma Procede de preparation de diamino-2,4 benzyl-5 pyrimidines
PT89780A (pt) * 1988-02-23 1989-10-04 Glaxo Group Ltd Processo para a preparacao de derivados da tetrahidroisoquinolina
JPH01308229A (ja) * 1988-02-23 1989-12-12 Glaxo Group Ltd 複素環誘導体
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
FR2642758B1 (fr) * 1989-02-09 1991-05-17 Esteve Labor Dr Derives de pyrimidine,2-(4-((alpha)-heteroaryl-(alpha) aryl-((alpha)-alkyl)-methoxy)-butyl)-1-piperazinyl), avec activite serotoninergique
US5136080A (en) * 1989-12-04 1992-08-04 Burroughs Wellcome Co. Nitrile compounds
GB9012316D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
WO1992002513A1 (en) * 1990-08-06 1992-02-20 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compounds

Also Published As

Publication number Publication date
ES2095842T3 (es) 1997-03-01
ATE144422T1 (de) 1996-11-15
NO894887L (no) 1990-06-08
EP0727213A3 (en) 1997-09-10
ES2300513T3 (es) 2008-06-16
CN1119099A (zh) 1996-03-27
IL111627A (en) 1997-06-10
NZ260820A (en) 1996-04-26
NO954489D0 (no) 1995-11-08
DK175796B1 (da) 2005-02-21
NZ231650A (en) 1996-03-26
EP0713703A3 (en) 1997-10-01
AP8900155A0 (en) 1990-01-31
DE68929460T2 (de) 2003-12-24
SK279988B6 (sk) 1999-06-11
IL92558A (en) 1996-01-31
US5587380A (en) 1996-12-24
IL114335A0 (en) 1995-10-31
US5684005A (en) 1997-11-04
SK689889A3 (en) 1999-06-11
CN1117046A (zh) 1996-02-21
DE68929540D1 (de) 2005-12-01
KR900009610A (ko) 1990-07-05
IL92558A0 (en) 1990-08-31
EP0372934A3 (en) 1992-07-15
NO954490L (no) 1990-06-08
EP0727213B9 (en) 2007-11-07
HUT55764A (en) 1991-06-28
RU2079493C1 (ru) 1997-05-20
NO941211D0 (no) 1994-04-05
NO178926C (no) 1996-07-03
PT92502B (pt) 1995-08-09
ES2194884T3 (es) 2003-12-01
IL113818A0 (en) 1995-08-31
CY2139B1 (en) 2002-06-21
HU211974A9 (en) 1996-01-29
EP0727212A3 (en) 1997-10-01
HU896444D0 (en) 1990-02-28
IL114019A0 (en) 1995-10-31
AU4596489A (en) 1990-06-14
AP164A (en) 1992-01-12
JPH02202876A (ja) 1990-08-10
DD292250A5 (de) 1991-07-25
SK32198A3 (en) 1999-06-11
EP1325916A1 (en) 2003-07-09
IL111627A0 (en) 1995-01-24
NO894887D0 (no) 1989-12-06
FI955940A (fi) 1995-12-11
EP1681058A2 (en) 2006-07-19
HK1004092A1 (en) 1998-11-13
LV10442B (en) 1995-08-20
DE68929554T2 (de) 2009-01-29
KR0145308B1 (ko) 1998-07-15
IL114040A0 (en) 1995-10-31
AU690443B2 (en) 1998-04-23
PL162957B1 (pl) 1994-01-31
UA42885C2 (uk) 2001-11-15
AU5195596A (en) 1996-07-04
EP0715851A3 (en) 1997-10-01
LT3415B (en) 1995-09-25
MC2076A1 (fr) 1990-10-12
FI955940A0 (fi) 1995-12-11
AU5195396A (en) 1996-07-04
RU2121998C1 (ru) 1998-11-20
ATE384703T1 (de) 2008-02-15
FI955941A0 (fi) 1995-12-11
IE893894L (en) 1990-06-07
US5712276A (en) 1998-01-27
DK175781B1 (da) 2005-02-21
OA09148A (en) 1991-10-31
NZ244881A (en) 1996-03-26
JP2795498B2 (ja) 1998-09-10
US5635507A (en) 1997-06-03
EP0727214A3 (en) 1997-10-01
MY115951A (en) 2003-10-31
LTIP269A (en) 1994-10-25
SK279977B6 (sk) 1999-06-11
HU211677A9 (en) 1995-12-28
CA2004747C (en) 2000-05-30
PT92502A (pt) 1990-06-29
CN1115756A (zh) 1996-01-31
DE68927368T2 (de) 1997-03-13
NO954490D0 (no) 1995-11-08
ATE307585T1 (de) 2005-11-15
CN1066719C (zh) 2001-06-06
AU4915493A (en) 1994-01-13
US5591746A (en) 1997-01-07
EP0372934B1 (en) 1996-10-23
EP0727213B1 (en) 2005-10-26
DK613289D0 (da) 1989-12-06
CA2004747A1 (en) 1990-06-07
IE80711B1 (en) 1998-12-16
US5597827A (en) 1997-01-28
AU5195296A (en) 1996-07-18
EP0715851B1 (en) 2003-04-02
MX9203422A (es) 1992-07-01
EP0727214A2 (en) 1996-08-21
CN1052306A (zh) 1991-06-19
DK613289A (da) 1990-06-08
DE68929540T2 (de) 2006-06-14
DE68929460D1 (de) 2003-05-08
CA2271566C (en) 2003-02-04
US5597828A (en) 1997-01-28
AU669929B2 (en) 1996-06-27
DK199900903A (da) 1999-06-24
PH31658A (en) 1999-01-12
GR3022031T3 (en) 1997-03-31
NO954489L (no) 1990-06-08
EP0372934A2 (en) 1990-06-13
FI955941A (fi) 1995-12-11
AU5195696A (en) 1996-07-04
ES2250967T3 (es) 2006-04-16
NO941211L (no) 1990-06-08
EP1325916B1 (en) 2008-01-23
EP0713703A2 (en) 1996-05-29
CN1066720C (zh) 2001-06-06
EP0727213A2 (en) 1996-08-21
EP0715851A2 (en) 1996-06-12
GEP19970891B (en) 1997-11-27
AU639216B2 (en) 1993-07-22
DE68927368D1 (de) 1996-11-28
EP0727212A2 (en) 1996-08-21
CN1113487A (zh) 1995-12-20
LV10442A (lv) 1995-02-20
SG43314A1 (en) 1997-10-17
NO304649B1 (no) 1999-01-25
EP1681058A3 (en) 2008-04-16
FI895821A0 (fi) 1989-12-05
NO178926B (no) 1996-03-25
FI955939A0 (fi) 1995-12-11
CA2271566A1 (en) 1990-06-07
NZ244880A (en) 1996-03-26
DE68929554D1 (de) 2008-03-13
FI955939A (fi) 1995-12-11
IL114335A (en) 2000-12-06
ATE235906T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
UA41245C2 (uk) Похідні піримідину, спосіб їх одержання та фармацевтична композиція на їх основі
DE69223965D1 (de) Anticonvulsives aminosäurederivat
DE69033308D1 (de) Decahydro-isochinolin-derivate
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
RU93049265A (ru) Производные декагидроизохинолинов, способ получения, фармацевтическая композиция
DK0850215T3 (da) N-(aroyl)glycinhydroxamsyrederivater og beslægtede forbindelser
NO944578L (no) Eksitatoriske aminosyre reseptor antagonister
NO963850D0 (no) Heterosykliske forbindelser, deres fremstilling og anvendelse
IE902288L (en) Tetrazolylmethylpiperidine carboxylic acid
BE882833A (fr) Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote, en utilisant pour traiter des desordres renaux
PT97478A (pt) Processo de producao de derivados n-(3-fluoro-2-fosfonilmetoxipropilo) de bases puricas e pirimidicas heterociclicas e de composicoes farmaceuticas que os contem
MX14957A (es) Nuevos derivados de tetrazol y procedimiento para su preparacion.
SE9300758D0 (sv) Process for the production of clavulanic acid
DK161889D0 (da) Aminforbindelse og fremgangsmaade til fremstilling deraf
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
FR2675804B1 (fr) Procede de synthese de peptides, nouveaux derives d'acides amines mis en óoeuvre dans ce procede et leurs procedes de preparation.
PT75949B (fr) Procede pour la preparation de derives d'acides amines en n-(vinblastinoil-23)
IT8721697A0 (it) Derivati dell'acido 7-ossabiciclo (2.2.1.) eptan idrossammico utili come inibitori duplici
DE3868051D1 (de) Potenzierung der antihypertensiven wirkung von ace-inhibitoren.
DK65691A (da) 2-aminocarboxylsyre-derivater, deres fremstilling og anvendelse som laegemidler
DE69722816D1 (de) Neue derivate von benzoylalkyl-1,2,3,6-tetrahydropyridinen
TH8810EX (th) สารประกอบที่ออกฤทธิ์ทางสรีรวิทยาสำหรับระบบประสาทส่วนกลาง
RU93044977A (ru) Ароматические производные аминов и способ их получения
IL77451A (en) Antihypertensive n-(substituted amino)alkanoylated cyclic amine derivatives,pharmaceutical compositions containing them and processes for the preparation of the agents and compositions